Showing results (391-400 of 618) with videos related to
Sort By:
Pageof 62
Revue Medicale De Liege|September 28, 2011
[Glycemic control before and after sitagliptin in general medical practice: analysis of determinant factors in the Belgian observational study "SUGAR"]A J Scheen, L F Van GaalRevue Medicale De Liege|November 20, 2010
[Clinical study of the month. Accord-lipid and accord-eye: towards a new positioning of fenofibrate in the management of type 2 diabetes]A J Scheen, L F Van GaalRevue Medicale De Liege|July 29, 2014
[Diabetes mellitus in the elderly: from the epidemiological challenge to a personalized approach]A J Scheen, N Paquot, B BauduceauRevue Medicale De Liege|December 5, 2013
[Sitagliptin in the treatment of type 2 diabetes: insights five years after commercialisation]A J Scheen, L F Van GaalRevue Medicale De Liege|June 3, 2021
[Editorial. Oncology, at a turning point in its history]A J Scheen, Y Beguin, G JerusalemRevue Medicale De Liege|November 10, 2022
[Apexxnar®, 20-valent pneumococcal conjugate vaccine]A J Scheen, R Louis, M MoutschenDiabetes & Metabolism|May 25, 2020
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reportsA J Scheen, M Marre, C ThivoletRevue Medicale De Liege|November 21, 2002
[Smoking, insulin resistance and type 2 diabetes]D Magis, I Geronooz, A J ScheenRevue Medicale De Liege|August 28, 2003
[Prevention of diabetic nephropathy: from microalbuminuria to end-stage renal insufficiency]L Weekers, A J Scheen, G RoriveRevue Medicale De Liege|November 5, 2013
[Jentadueto, fixed combination of linagliptin plus metformin for the treatment of type 2 diabetes]A J Scheen, L F Van GaalPageof 62